Acorda Therapeutics (ACOR): Q4 EPS of $0.24 misses by $0.04. Revenue of $81.5M beats by $2.6M. (PR)

|About: Acorda Therapeutics, Inc. (ACOR)|By:, SA News Editor
Acorda Therapeutics (ACOR): Q4 EPS of $0.24 misses by $0.04. Revenue of $81.5M beats by $2.6M. (PR)